Financial Statements — VALE
Balance Sheet
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2021 |
|---|
| Cash & Equivalents | 5.51 | 6.48 | 13.65 |
| Inventory | 5.24 | 4.79 | 4.70 |
| Total Current Assets | 17.59 | 14.83 | 25.40 |
| Total Non-current Assets | 72.80 | 71.79 | 71.31 |
| Total Current Liabilities | 14.47 | 13.74 | 14.34 |
| Total Non-current Liabilities | 35.41 | 34.49 | 40.02 |
| Total Liabilities | 49.87 | 48.23 | 54.36 |
| Total Stockholder Equity | 40.51 | 38.39 | 42.36 |
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2021 |
|---|
| Total Revenue | 8.80 | 9.92 | 16.68 |
| Cost of Revenue* | 6.09 | 6.35 | 5.81 |
| Gross Profit | 2.72 | 3.57 | 10.87 |
| Total Operating Expenses* | 0.72 | (0.30) | 0.72 |
| Operating Income | 2.00 | 3.88 | 9.71 |
| Pretax Income | 2.10 | 2.74 | 9.61 |
| Tax Provision | (0.03) | 0.03 | 2.07 |
| Basic EPS | 0.50 | 0.65 | -- |
| Diluted EPS | 0.50 | 0.65 | -- |
* Derived from reported values
Cash Flow Statement
(in billions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2021 |
|---|
| Operating Cash Flow | 3.53 | -- | 7.73 |
| Investing Cash Flow | (3.37) | (0.28) | -- |
| Financing Cash Flow | 0.28 | (1.43) | -- |
